Simplex Trading
IMVT icon

Simplex Trading’s Immunovant IMVT Stock Holding History

Simplex Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.32M Sell
39,090
-11,990
-23% -$473K ﹤0.01% 2424
2026
Q2 		$1.97M Buy
51,080
+804
+2% +$24.5K ﹤0.01% 2060
2026
Q1 		$1.25M Buy
50,276
+1,865
+4% +$48.3K ﹤0.01% 2270
2025
Q4 		$1.23M Buy
48,411
+33,479
+224% +$747K ﹤0.01% 2425
2025
Q3 		$240K Buy
14,932
+10,126
+211% +$164K ﹤0.01% 4718
2025
Q2 		$76K Buy
+4,806
New +$72.7K ﹤0.01% 5495
2025
Q1 		– Sell
-86,847
Closed -$1.82M – 9012
2024
Q4 		$2.15M Buy
86,847
+38,656
+80% +$1.1M ﹤0.01% 2128
2024
Q3 		$1.37M Sell
48,191
-8,770
-15% -$259K ﹤0.01% 2608
2024
Q2 		$1.5M Buy
56,961
+31,972
+128% +$909K ﹤0.01% 2482
2024
Q1 		$807K Sell
24,989
-52,493
-68% -$1.92M ﹤0.01% 3348
2023
Q4 		$3.26M Sell
77,482
-47,730
-38% -$1.76M ﹤0.01% 1922
2023
Q3 		$4.81M Buy
125,212
+104,706
+511% +$2.37M ﹤0.01% 1383
2023
Q2 		$388K Buy
20,506
+4,652
+29% +$86.8K ﹤0.01% 3566
2023
Q1 		$245K Buy
15,854
+7,362
+87% +$128K ﹤0.01% 4096
2022
Q4 		$150K Sell
8,492
-1,085
-11% -$13.7K ﹤0.01% 4587
2022
Q3 		$53K Buy
9,577
+9,522
+17,313% +$46.5K ﹤0.01% 6370
2022
Q2 		$0 Buy
+55
New +$238 ﹤0.01% 10454
2022
Q1 		– Sell
-4,019
Closed -$25K – 10861
2021
Q4 		$34K Sell
4,019
-6,781
-63% -$56K ﹤0.01% 7733
2021
Q3 		$122K Buy
10,800
+6,296
+140% +$56.8K ﹤0.01% 6334
2021
Q2 		$47K Buy
+4,504
New +$62.9K ﹤0.01% 7705

Other funds holding IMVT

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Simplex Trading's IMVT Position: Q3 2026 in Review

Simplex Trading reduced its Immunovant (IMVT) stake by 23% in Q3 2026, selling an estimated $473K and leaving 39,090 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2424.

Simplex Trading first reported a position in IMVT in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.81M in Q3 2023. 50 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Simplex Trading held 39,090 shares of Immunovant worth $1.32M as of Q3 2026.
  • Simplex Trading sold 11,990 Immunovant shares in Q3 2026, an estimated $473K.
  • Immunovant made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #2424 holding.
  • Simplex Trading first reported a position in Immunovant in Q2 2021 and has held it in 20 quarters since.
  • Simplex Trading's Immunovant position peaked at $4.81M in Q3 2023.
  • 50 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.